<DOC>
	<DOCNO>NCT02088021</DOCNO>
	<brief_summary>The purpose clinical investigation evaluate use Portico ALC Delivery System place transcatheter aortic valve alternative access site , specifically subclavian/axillary TAo .</brief_summary>
	<brief_title>Assessment St. Jude Medical PorticoTM Re-sheathable Aortic Valve System - Alternative Access</brief_title>
	<detailed_description />
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<criteria>Subject provide write informed consent . Subject 65 year age old time index procedure , and/or comorbidities , opinion Principal Investigator Subject Selection Committee , preclude surgical valve replacement . Subject 's aortic annulus diameter meet range indicated Instructions Use measure multislice CT conduct within 120 day prior index procedure . Subject senile degenerative aortic stenosis echocardiography within 30 day index procedure define least 1 follow : derive mean gradient great 40 mmHg , OR jet velocity great 4.0 m/s , OR aortic valve area le 0.8 cm2 , OR aortic valve area index less equal 0.6 cm2/m2 . Subject symptomatic aortic stenosis demonstrate NYHA Functional Classification II , III , IV . Subject deem high operable risk delivery route suitable TAVI per medical opinion Subject Selection Committee . Subject 's predicted operative mortality serious , irreversible morbidity risk le 50 % 30 day post index procedure . Subject unwilling unable comply studyrequired followup evaluation . Subject documented history cerebral vascular accident ( CVA ) transient ischemic attack ( TIA ) within 6 month ( less equal 180 day ) prior index procedure . Subject carotid artery disease require intervention . Evidence acute myocardial infarction ( MI ) within 30 day prior patient provide consent ( define : ST Segment Elevation evidence 12 Lead ECG ) . Subject native aortic valve congenitally unicuspid , bicuspid , quadricuspid noncalcified see echocardiography . Subject mitral valvular regurgitation great grade III . Subject moderate severe mitral stenosis . Subject preexist prosthetic cardiac device , valve , prosthetic ring position . Subject refuse blood product transfusion . Subject refuse surgical valve replacement . Subject leave ventricular ejection fraction ( LVEF ) less 20 % . Subject document , untreated symptomatic coronary artery disease ( CAD ) require revascularization . Subject percutaneous interventional invasive cardiovascular peripheral vascular procedure less equal 14 day index procedure . Subject severe basal septal hypertrophy would interfere transcatheter aortic valve placement . Subject history , currently diagnose endocarditis . There image evidence intracardiac mass , thrombus , vegetation . Subject consider hemodynamically unstable ( require inotropic support mechanical heart assistance ) . Subject acute pulmonary edema require intravenous diuretic therapy stabilize heart failure . Subject significant pulmonary disease determine documented Investigator . Subject significant chronic steroid use determine documented Investigator . Subject document hypersensitivity contraindication anticoagulant antiplatelet medication . Subject renal insufficiency evidence serum creatinine great 3.0 mg/dL ( 265.5 µmol/L ) endstage renal disease require chronic dialysis . Subject morbid obesity define BMI great equal 40 . Subject ongoing infection sepsis . Subject blood dyscrasia ( eg , leukopenia , acute anemia , thrombocytopenia , history bleeding diathesis , coagulopathy ) . Subject current autoimmune disease , opinion Principal Investigator Subject Selection Committee , precludes subject study participation . Significant ascend aortic disease document diameter great 40mm . Subject active peptic ulcer gastrointestinal ( GI ) bleed within 90 day prior index procedure . Subject currently participate another investigational drug device study . Subject require emergency surgery reason . Subject life expectancy le 12 month . Subject medical , social psychological condition , opinion Principal Investigator Subject Selection Committee , preclude subject study participation . Subject diagnose dementia admit chronic care facility would fundamentally complicate rehabilitation procedure compliance followup visit . Subject unwilling unable comply studyrequired followup evaluation . Subject documented history cerebral vascular accident ( CVA ) transient ischemic attack ( TIA ) within 6 month ( less equal 180 day ) prior index procedure . Subject carotid artery disease require intervention . Evidence acute myocardial infarction ( MI ) within 30 day prior patient provide consent ( define : ST Segment Elevation evidence 12 Lead ECG ) . Subject native aortic valve congenitally unicuspid , bicuspid , quadricuspid noncalcified see echocardiography . Subject mitral valvular regurgitation great grade III . Subject moderate severe mitral stenosis . Subject preexist prosthetic cardiac device , valve , prosthetic ring position . Subject refuse blood product transfusion . Subject refuse surgical valve replacement . Subject leave ventricular ejection fraction ( LVEF ) less 20 % . Subject document , untreated symptomatic coronary artery disease ( CAD ) require revascularization . Cardiovascular peripheral vascular procedure less equal 14 day index procedure . Subject severe basal septal hypertrophy would interfere transcatheter aortic valve placement . Subject history , currently diagnose endocarditis . There image evidence intracardiac mass , thrombus , vegetation . Subject consider hemodynamically unstable ( require inotropic support mechanical heart assistance ) . Subject acute pulmonary edema require intravenous diuretic therapy stabilize heart failure . Subject significant pulmonary disease determine documented Investigator . Subject significant chronic steroid use determine documented Investigator . Subject document hypersensitivity contraindication anticoagulant antiplatelet medication . Subject renal insufficiency evidence serum creatinine great 3.0 mg/dL ( 265.5 µmol/L ) endstage renal disease require chronic dialysis . Subject morbid obesity define BMI great equal 40 . Subject ongoing infection sepsis . Subject blood dyscrasia ( eg , leukopenia , acute anemia , thrombocytopenia , history bleeding diathesis , coagulopathy ) . Significant ascend aortic disease document diameter great 40mm . Subject active peptic ulcer gastrointestinal ( GI ) bleed within 90 day prior index procedure . Subject currently participate another investigational drug device study . Subject require emergency surgery reason . Subject life expectancy le 12 month . Subject medical , social psychological condition , opinion Principal Investigator Subject Selection Committee , preclude subject study participation . Subject diagnose dementia admit chronic care facility would fundamentally complicate rehabilitation procedure compliance followup visit . Subject document allergy contrast medium , nitinol alloy , porcine tissue , bovine tissue .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>